Metabolic aspects of programmed cell survival and cell death in the heart

Cardiovascular Research

Volumn 45, Issue 3, 2000, Pages 538-548

  Depre, Christophe ^a   Taegtmeyer, Heinrich ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Energy metabolism; Gene expression; Heart failure; Hibernation; Stunning

Indexed keywords

GLUCOSE;

APOPTOSIS; CELL SURVIVAL; ENERGY METABOLISM; ENERGY TRANSFER; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HIBERNATION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; CELL SURVIVAL; ENERGY METABOLISM; GENE EXPRESSION; GLUCOSE; GLYCOGEN; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NITRIC OXIDE;

EID: 0033979080     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00266-7     Document Type: Review

References (176)

1. Langendorff O. Untersuchungen am uberlebenden Saugethierherzen. Arch Ges Physiol Menschen Tiere. 61:1895;291-332.
2. MacLellan W., Schneider M. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res. 81:1997;137-144.
3. Haunstetter A., Izumo S. Apoptosis: Basic mechanism and implication for cardiovascular disease. Circ Res. 82:1998;1111-1129.
4. Olivetti G., Abbi R., Quaini F., et al. Apoptosis in human failing heart. New Engl J Med. 336:1997;1131-1141.
5. Taegtmeyer H., Roberts A.F.C., Rayne A.E.G. Energy metabolism in reperfused rat heart: Return of function before normalization of ATP content. J Am Coll Cardiol. 6:1985;864-870.
6. Taegtmeyer H., Hems R., Krebs H.A. Utilization of energy providing substrates in the isolated working rat heart. Biochem J. 186:1980;701-711.
7. Goodwin G., Taylor C., Taegtmeyer H. Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem. 273:1998;29530-29539.
8. Garland P.B., Randle P.J., Newsholme E.A. Citrate as an intermediary in the inhibition of phosphofructokinase in rat heart muscle by fatty acids, ketone bodies, pyruvate, diabetes and starvation. Nature (London). 200:1963;169-170.
9. Randle P.J., Newsholme E.A., Garland P.B. Regulation of glucose uptake by muscle. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochemistry. 93:1964;652-687.
10. Awan M.M., Saggerson E.D. Malonyl-Co A metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem J. 295:1993;61-66.
11. Saddik M., Gamble J., Witters L.A., Lopaschuk G.D. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem. 268:1993;25836-25845.
12. Gertz E.W., Wisneski J.A., Stanley W.C., Neese R.A. Myocardial substrate utilization during exercise in humans. J Clin Invest. 82:1988;2017-2025.
13. Taegtmeyer H. On the inability of ketone bodies to serve as the only energy providing substrate for rat heart at physiological work load. Basic Res Cardiol. 78:1983;435-450.
14. Depre C., Veitch K., Hue L. Role of fructose 2,6-bisphosphate in the control of glycolysis. Stimulation of glycogen synthesis by lactate in the isolated working rat heart. Acta Cardiol. 48:1993;147-164.
15. Depre C., Ponchaut S., Deprez J., Maisin L., Hue L. Cyclic AMP suppresses the inhibition of glycolysis by alternative oxidizable substrates in the heart. J Clin Invest. 101:1998;390-397.
16. Neely J., Denton R., England P., Randle P. The effects of increased heart work on the tricarboxylic cycle and its interactions with glycolysis in the perfused rat heart. Biochem J. 128:1972;147-159.
17. Taegtmeyer H. Carbohydrate interconversions and energy production. Circulation. 72:1985;1-8.
18. Wheeler T.J. Translocation of glucose transporters in response to anoxia in heart. J Biol Chem. 263:1988;19447-19454.
19. Zaninetti D., Greco-Perotto R., Jeanrenaud B. Heart glucose transport and transporters in rat heart: Regulation by insulin, workload and glucose. Diabetologia. 31:1988;108-113.
20. Collins-Nakai R.L., Noseworthy D., Lopaschuk G.D. Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism. Am J Physiol. 267:1994;H1862-71.
21. Van Bilsen M., Van der Vusse G., Reneman R. Transcriptional regulation of metabolic processes: implications for cardiac metabolism. Pflügers Arch. 437:1998;2-14.
22. Stanley W.C., Lopaschuk G.D., McCormack J.G. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res. 34:1997;25-33.
23. Camps M., Castelló A., Muñoz P., et al. Effect of diabetes and fasting on GLUT-4 (muscle/fat) glucose-transporter expression in insulin-sensitive tissues. Biochem J. 282:1992;765-772.
24. Dillmann W. Diabetes mellitus induces changes in cardiac myosin of the rat. Diabetes. 29:1980;579-582.
25. Rodrigues B., Goyal R., McNeill J. Effects of hydralazine on streptozotocin-induced diabetic rats: prevention of hyperlipidemia and improvement in cardiac function. J Pharmacol Exp Ther. 237:1986;292-299.
26. Litwin S., Raya T., Anderson P., Daugherty S., Goldman S. Abnormal cardiac function in the streptozotocin-diabetic rat. J Clin Invest. 86:1990;481-488.
27. Nadal-Ginard B., Mahdavi V. Molecular basis of cardiac performance: plasticity of the myocardium generated through protein isoform switches. J Clin Invest. 84:1989;1693-1700.
28. Sadoshima S., Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol. 59:1997;551-571.
29. Depre C., Shipley G., Chen W., et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nature Med. 4:1998;1269-1275.
30. Depre C., Davies P., Taegtmeyer H. Transcriptional adaptation of the heart to mechanical unloading. Am J Cardiol. 83:1999;58H-63H.
31. Murphy A. Contractile protein phenotypic variation during development. Cardiovasc Res. 31:1996;E25-E33.
32. Gottlieb R., Burleson K., Kloner R., Babior B., Engler R. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.
33. Tanaka M., Ito H., Adachi S., et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 75:1994;426-433.
34. Long X., Boluyt M., Hipolito M., et al. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest. 99:1997;2635-2643.
35. Ma X., Kumar S., Gao F., et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation. 99:1999;1685-1691.
36. Yaoita H., Ogawa K., Machara K., Maruyama Y. Attenuation of ischemia-reperfusion injury in rats by a caspase inhibitor. Circulation. 97:1998;276-281.
37. Angello D.A., Berne R.M., Coddington N.M. Adenosine and insulin mediate glucose uptake in normoxic hearts by different mechanisms. Am J Physiol. 265:1993;H880-H885.
38. Katz A.M., Hecht H.H. The early 'pump' failure of the ischemic heart. Am J Med. 47:1969;497-502.
39. Jennings R., Hawkins H., Lowe J., et al. Relation between high energy phosphate and lethal injury in myocardial ischemia. Am J Pathol. 92:1978;187.
40. 2+ overload - a new principle in cardiac pathophysiology. Rec Adv Stud Card Struct Met. 4:1974;563-580.
41. Katz A., Reuter H. Cellular calcium and cell death. Am J Cardiol. 44:1979;188.
42. McElroy D.D., Walker W.E., Taegtmeyer H. Glycogen loading improves left ventricular function of the rabbit heart after hypothermic ischemic arrest. J Appl Cardiol. 4:1989;455-465.
43. Schneider C.A., Taegtmeyer H. Fasting in vivo delays myocardial cell damage after brief periods of ischemia in the isolated working rat heart. Circ Res. 68:1991;1045-1050.
44. Doenst T., Guthrie P., Chemnitius J.-M., Zech R., Taegtmeyer H. Fasting, lactate, and insulin improve ischemia tolerance: a comparison with ischemic preconditioning. Am J Physiol. 270:1996;H1607-H1615.
45. Ross J.J. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation. Circulation. 83:1991;1076-1083.
46. Bristow J.D., Arai A.E., Anselone C.G., Pantely G.A. Response to myocardial ischemia as a regulated process. Circulation. 84:1991;2580-2587.
47. Krebs H. The Pasteur effect and the relation between respiration and fermentation. Essays Biochem. 8:1972;1-34.
48. Morgan H E., Henderson M J., Regen D M., Park C R. Regulation of glucose uptake in muscle. I. The effects of insulin and anoxia on glucose transport and phosphorylation in the isolated perfused heart of normal rats. J Biol Chem. 236:1961;253-261.
49. De Boer L., Rude R., Kloner R., et al. A flow- and time-dependent index of ischemic injury after coronary occlusion and reperfusion. Proc Natl Acad Sci USA. 80:1983;5784-5788.
50. Bolukoglu H., Goodwin G.W., Guthrie P.H., Carmical S G., Chen T.M., Taegtmeyer H. Metabolic fate of glucose in reversible low-flow ischemia of the isolated working rat heart. Am J Physiol. 270:1996;H817-H826.
51. Chen T.M., Goodwin G.W., Guthrie P.H., Taegtmeyer H. Effects of insulin on glucose uptake by rat hearts during and after coronary flow reduction. Am J Physiol. 273:1997;H2170-H2177.
52. Young L.H., Renfu Y., Russell R., et al. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation. 95:1997;415-422.
53. Vanoverschelde J.L., Janier M.F., Bakke J.E., Marshall D.R., Bergmann S.R. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol. 267:1994;H1785-H1794.
54. Sun D., Nguyen N., Delgrado T.R., Schwaiger M., Brosius F.C.I. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT 4 to the plasma membrane of cardiac myocytes. Circulation. 89:1994;793-798.
55. Depre C., Rider M., Hue L. Mechanisms of control of heart glycolysis. Eur J Biochem. 258:1998;277-290.
56. Russell R., Cline G., Guthrie P., et al. Regulation of exogenous and endogenous glucose metabolism by insulin and acetoacetate in isolated working rat heart: A three-tracer study of glycolysis, glycogen metabolism and glucose oxidation. J Clin Invest. 100:1997;2892-2899.
57. Depre C., Rider M.H., Veitch K., Hue L. Role of fructose-2, 6-bisphosphate in the control of heart glycolysis. J Biol Chem. 268:1993;13274-13279.
58. Stanley W., Hall J., Stone C., Hacker T. Acute myocardial ischemia causes a transmural gradient in glucose extraction but not glucose uptake. Am J Physiol. 262:1992;H91-H96.
59. Neely J R., Grotyohann L.W. Role of glycolytic products in damage to myocardium: Dissociation of adenosine triphosphate levels and recovery of function of reperfused canine myocardium. Circ Res. 55:1984;816-824.
60. Bricknell O.L., Daries P.S., Opie L.H. A relationship between adenosine triphosphate, glycolysis and ischaemic contracture in the isolated rat heart. J Mol Cell Cardiol. 13:1981;941-945.
61. 2+] elevation and ATP depletion. Am J Physiol. 258:1990;H9-H16.
62. Steenbergen C., Murphy E., Watts J., London R. Correlation between cytosolic free calcium, contracture. ATP, and irreversible ischemic injury in perfused rat heart. Circ Res. 66:1990;135-146.
63. Depre C., Vanoverschelde J.-L., Goudemant J.-F., Mottet I., Hue L. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation. 92:1995;1911-1918.
64. Apstein C S., Gravino F.N., Haudenschild C.C. Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion. Circ Res. 52:1983;515-526.
65. Eberli F.R., Weinberg E.O., Grice W.N., Horowitz G.L., Apstein C.S. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res. 68:1991;466-481.
66. King L.M., Boucher F., Opie L.H. Coronary flow and glucose delivery as determinants of contracture in the ischemic myocardium. J Mol Cell Cardiol. 27:1995;701-720.
67. Ladilov Y., Siegmund B., Piper H. Protection of reoxygenated cardiomyocytes against hypercontracture by inhibition of Na+/H+ exchange. Am J Physiol. 268:1995;H1531-H1539.
68. Ladilov Y., Siegmund B., Balser C., Piper H. Simulated ischemia increases the susceptibility of rat cardiomyocytes to hypercontracture. Circ Res. 80:1997;69-75.
69. Bak M., Ingwall J. Acidosis during ischemia promotes adenosine triphosphate resynthesis in post-ischemic rat heart. J Clin Invest. 93:1994;40-49.
70. 3. New Engl J Med. 314:1986;884-888.
71. Borgers M., Thoné F., Wouters L., et al. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis. Cardiovasc Pathol. 2:1993;237-245.
72. Maes A., Flameng W., Nuyts J., et al. Histological alterations in chronically hypo-perfused myocardium. Correlation with PET findings. Circulation. 90:1994;735-745.
73. Depre C., Vanoverschelde J.L., Gerber B., et al. Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 113:1997;82-87.
74. Reimer K.A., Murry C.E., Yamasawa I., Hill M.L., Jennings R.B. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol. 251:1986;H1306-H1315.
75. 1 adenosine receptors in rabbit heart. Circulation. 84:1991;350-356.
76. Murry C.E., Richard V.J., Reimer K.A., Jennings R B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 66:1990;913-931.
77. Kida M., Fujiwara H., Ishida M., et al. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation. 84:1991;2495-2503.
78. Kolocassides K., Galinanes M., Hearse D. Preconditioning accelerates contracture and ATP depletion in blood-perfused rat hearts. Am J Physiol. 269:1995;H1415-H1420.
79. Baghelai K., Graham L., Wechsler A., Jakoi E. Delayed myocardial preconditioning by alpha1-adrenoceptors involves inhibition of apoptosis. J Thorac Cardiovasc Surg. 117:1999;980-986.
80. Gottlieb R., Gruol D., Zhu J., Engler R. Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest. 97:1996;2391-2398.
81. Heyndrickx G.R., Millard R.W., McRitchie R.J., Maroko P.R., Vatner S.F. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest. 56:1975;978-985.
82. Braunwald E., Kloner R.A. The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation. 66:1982;1146-1149.
83. Bolli R. Myocardial 'stunning' in man. Circulation. 86:1992;1671-1691.
84. Kloner R.A., Bolli R., Marban E., Reinlib L., Braunwald E. Medical and cellular implications of stunning, hibernation, and preconditioning. An NHLBI workshop. Circulation. 97:1998;1848-1867.
85. 2+-dependent proteolysis? Circ Res. 78:1996;455-465.
86. Bolli R. Mechanism of myocardial 'stunning'. Circulation. 82:1990;723-738.
87. +-ATPase. Am J Physiol. 252:1987;H252-H257.
88. 2+ pump by oxygen free radicals. Am J Physiol. 257:1989;H804-H811.
89. Packer M.A., Murphy M.P. Peroxynitrite causes calcium efflux from mitochondria which is prevented by cyclosporin A. FEBS Lett. 345:1994;237-270.
90. Coretti M.C., Koretsune Y., Kusuoka H., et al. Glycolytic inhibition and calcium overload as consequences of exogenously generated free radicals in rabbit hearts. J Clin Invest. 88:1991;1014-1025.
91. Vanoverschelde J.L., Wijns W., Borgers M., et al. Chronic myocardial hibernation in humans. From bedside to bench. Circulation. 95:1997;1961-1971.
92. Depre C., Vanoverschelde J.L., Melin J.A., et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol. 268:1995;H1265-H1275.
93. Elsasser A., Scxhleper M., Klovekorn W., et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation. 96:1997;2920-2931.
94. Maki M., Luotolahti M., Nuutila P., et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation. 93:1996;1658-1666.
95. Doenst T., Taegtmeyer H. Ischemia-stimulated glucose uptake does not require catecholamines in rat heart. J Mol Cell Cardiol. 31:1999;435-443.
96. Thompson E.W., Marino T.A., Uboh C.E., Kent R.L., Cooper G. Atrophy reversal and cardiocyte redifferentiation in reloaded cat myocardium. Circ Res. 54:1984;367-377.
97. Depre C., Havaux X., Dion R., Vanoverschelde J. Morphologic alterations of myocardium under left ventricular assistance. J Thorac Cardiovasc Surg. 115:1998;478-479.
98. Liedtke A.J., Demaison L., Nellis S.H. Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol. 255:1988;169-176.
99. Gorge G., Chatelain P., Schaper J., Lerch R. Effect of increasing degrees of ischemic injury on myocardial oxidative metabolism early after reperfusion in isolated rat hearts. Circ Res. 68:1991;1681-1692.
100. Benzi R.H., Lerch R. Dissociation between contractile function and oxidative metabolism in postischemic myocardium. Circ Res. 71:1992;567-576.
101. 2 during reperfusion of ischemic hearts. Am J Physiol. 270:1996;H72-H80.
102. Mallet R.T., Hartman D.A., Bünger R. Glucose requirement for postischemic recovery of perfused working heart. Eur J Biochem. 188:1990;481-493.
103. Jeremy R.W., Koretsune Y., Marban E., Becker L C. Relation between glycolysis and calcium homeostasis in postischemic myocardium. Circ Res. 70:1992;1180-1190.
104. Tamm C., Benzi R.H., Papageorgiou I., Tardy I., Lerch R. Substrate competition in postischemic myocardium. Effect of substrate availability during reperfusion on metabolic and contractile recovery in isolated rat hearts. Circ Res. 75:1994;1103-1112.
105. du Toit E.F., Opie L.H. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res. 70:1992;960-967.
106. McVeigh J.J., Lopaschuk G.D. Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol. 259:1990;H1079-H1085.
107. Murphy E., Perlman M., London R.E., Steenbergen C. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res. 68:1991;1250-1258.
108. 2+ overload in reperfused ischemic myocardium. Annu Rev Physiol. 52:1990;543-559.
109. Liu B., Clanachan A.S., Schulz R., Lopaschuk G.D. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res. 79:1996;940-948.
110. Factor S., Bhan R., Minase T., H W., Sonnenblick E. Hypertensive-diabetic cardiomyopathy in the rat. Am J Pathol. 102:1981;219-228.
111. 2+ ATPase in congestive heart failure due to diabetes. Angiology. 44:1993;769-775.
112. Doggrell S., Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res. 39:1998;89-105.
113. Adams J., Sakata Y., Davis M., et al. Enhanced Gαq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA. 95:1998;10140-10145.
114. Wang Y., Huang S., Sah V., et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem. 273:1998;2161-2168.
115. 2-terminal kinase pathway in H9c2 cardiac muscle cells. J Mol Cell Cardiol. 30:1998;1789-1801.
116. 2-terminal kinase in ventricular muscle cells. J Biol Chem. 273:1998;5423-5426.
117. 2-terminal kinase activity, and apoptosis. Mol Cell Biol. 19:1999;5659-5674.
118. Aikawa R., Komuro I., Yamazaki T., et al. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest. 100:1997;1813-1821.
119. Krown K., Page M., Nguyen C., et al. Tumor necrosis factor-alpha-induced apoptosis in cardiac myocytes. J Clin Invest. 98:1996;2854-2865.
120. Clerk A., Sugden P. Mitogen-activated protein kinases are activated by oxidative stress and cytokines in neonatal ventricular myocytes. Biochem Soc Trans. 25:1997;566S.
121. Sugden P., Clerk A. Stress-responsive mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res. 83:1998;345-352.
122. Adderley S., Fitzgerald D. Oxidative damage of cardiomyocytes is limited by extracellular-regulated kinases 1/2-mediated induction of cyclooxygenase-2. J Biol Chem. 274:1999;5038-5046.
123. Erhardt P., Schremser E., Cooper G. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/ERK pathway. Mol Cell Biol. 19:1999;5308-5315.
124. Kennedy S., Kandel E., Cross T., Hay N. Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol. 19:1999;5800-5810.
125. Molkentin J., Lu J., Antos C., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:1998;215-228.
126. Sussman M., Lim H., Gude N., et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 281:1998;1690-1693.
127. 2+/calmodulin dependent protein kinase cascade in the hog heart. Biochem Biophys Res Commun. 249:1998;355-360.
128. 2+-calmodulin-dependent protein cascade cascade. Trends Biochem Sci. 24:1999;232-236.
129. Cardone M., Roy N.H.R.S., Stennicke H.R., et al. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1998;1318-1321.
130. Zamzani N., Marchetti P., Castedo M., Zanin C., Vayssiere J., Petit P., Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med. 181:1995;1661-1672.
131. Zamzani N., Marchetti P., Castedo M., et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med. 182:1995;367-377.
132. Narula J., Pandey P., Arbustini E., et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA. 96:1999;8144-8149.
133. Saikumar P., Dong Z., Weinberg J., Venkatachalan M. Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene. 17:1998;3341-3349.
134. Kan O., Baldwin S., Whetton A. Apoptosis regulated by the rate of glucose transport in an interleukin-3 dependent cell line. J Exp Med. 180:1994;917-923.
135. Berridge M., Tan A., McCoy K., Kansara M., Rudert F. CD95 (Fas/Apo-1)-induced apoptosis results in loss of glucose transporter function. J Immunol. 156:1996;4092-4099.
136. Marton A., Mihalik R., Bratincsak A., et al. Apoptotic cell death induced by inhibitors of energy conservation. Eur J Biochem. 250:1997;467-475.
137. Kirshenbaum L., de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation. 96:1997;1580-1585.
138. Garland J., Halestrap A. Energy metabolism during apoptosis. Bcl-2 promotes cell survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest. J Biol Chem. 272:1997;4680-4688.
139. Eguchi Y., Shimizu S., Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57:1997;1835-1840.
140. Taimor G., Lorenz H., Hofstaetter B., Schluter K., Piper H. Induction of necrosis but not apoptosis after anoxia and reoxygenation in isolated adult cardiomyocytes of rat. Cardiovasc Res. 41:1999;147-156.
141. Scheuer J. Metabolic factors in myocardial failure. Circulation. 87:1993;VII54-VII57.
142. Sack M.N., Rader T.A., Park S., et al. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 94:1996;2837-2842.
143. Sack M.N., Disch D.L., Rockman H.A., Kelly D P. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophy growth program. Proc Natl Acad Sci USA. 94:1997;6438-6443.
144. Depre C., Shipley G., Davies P., Frazier O., Taegtmeyer H. Glucose transporter isoform expression in the failing human heart. Abstract Circulation. 98:1998;I-627.
145. Gradinak S., Coleman G.M., Taegtmeyer H., Sweeney M.S., Frazier O.H. Improved cardiac function with glucose-insulin-potassium after coronary bypass surgery. Ann Thorac Surg. 48:1989;484-489.
146. Lazar H.L. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions. J Card Surg. 9:(Suppl):1994;474-478.
147. Taegtmeyer H., Goodwin G.W., Doenst T., Frazier O.H. Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol. 80:1997;3A-10A.
148. Depre C., Vanoverschelde J., Taegtmeyer H. Glucose for the heart. Circulation. 99:1999;578-588.
149. Malhotra R., Brosius F. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. J Biol Chem. 274:1999;12567-12575.
150. Recchia F., McConnell P., Bernstein R., et al. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res. 83:1998;969-979.
151. Depre C., Gaussin V., Ponchaut S., et al. Inhibition of myocardial glucose uptake by cGMP. Am J Physiol. 274:1998;H1443-H1449.
152. Arstall M., Bailey C., Gross W., et al. Reversible S-nitrosation of creatine kinase by nitric oxide in adult rat ventricular myocytes. J Mol Cell Cardiol. 30:1998;979-988.
153. Kaasik A., Minajeva A., De Sousa E., Ventura-Clapier R., Veksler V. Nitric oxide inhibits cardiac energy production via inhibition of mitochondrial creatine kinase. FEBS Lett. 444:1999;75-77.
154. Sharpe M., Cooper C. Reactions of nitric oxide with mitochondrial cytochrome c: a novel mechanism for the formation of nitroxyl anion and peroxynitrite. Biochem J. 332:1998;9-19.
155. Brown G. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta. 1411:1999;351-369.
156. Knowles R., Moncada S. Nitric oxide synthases in mammals. Biochem J. 298:1994;249-258.
157. Hare J., Stamler J. NOS: modulator, not mediator of cardiac performance. Nature Med. 5:1999;273-274.
158. Li J., Bombeck C., Yang S., Kim Y., Billiar T. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J Biol Chem. 274:1999;17325-17333.
159. Murphy M. Nitric oxide and cell death. Biochim Biophys Acta. 1411:1999;401-414.
160. Virag L., Szabo C. Inhibition of poly(ADP-ribose) synthetase (PARS) and protection against peroxynitrite-induced cytotoxicity by zinc chelation. Br J Pharmacol. 126:1999;769-777.
161. Stefanelli C., Pignatti C., Tantini B., et al. Nitric oxide can function as either a killer molecule or an antiapoptotic effector in cardiomyocytes. Biochim Biophys Acta. 1450:1999;406-413.
162. Bosca L., Hortelano S. Mechanisms of nitric oxide-dependent apoptosis: involvement of mitochondrial mediators. Cell Signal. 11:1999;239-244.
163. Leist M., Single B., Naumann H., et al. Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis. Exp Cell Res. 249:1999;396-403.
164. Nakao K., Minobe W., Roden R., Bristow M.R., Leinwand L.A. Myosin heavy chain gene expression in human heart failure. J Clin Invest. 100:1997;2362-2370.
165. 2+-ATPase gene expression in human ventricle during end-stage heart failure. J Clin Invest. 85:1990;305-309.
166. 2+-ATPase in failing and non-failing human myocardium. Circ Res. 75:1994;434-442.
167. Ungerer M., Bohm M., Elce J.S., Erdmann E., Lohse M.J. Altered expression of β-adrenergic receptor kinase and b1-adrenergic receptors in the failing human heart. Circulation. 87:1993;454-463.
168. Bristow M.R., Minobe W.A., Raynolds M.V., et al. Reduced b1 receptor messenger RNA abundance in the failing human heart. J Clin Invest. 92:1993;2737-2745.
169. Lowes B D., Minobe W., Abraham W.T., et al. Changes in gene expression in the intact human heart. J Clin Invest. 100:1997;2315-2324.
170. Arai M., Matsui H., Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res. 74:1994;555-564.
171. Teiger E., Than V., Richard L., et al. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest. 97:1996;2891-2897.
172. Bialik S., Geenen D., Sasson I., et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest. 100:1997;1363-1372.
173. Meldrum D. Tumor necrosis factor in the heart. Am J Physiol. 274:1998;R577-R595.
174. Von Harsdorf R., Li P., Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation. 99:1999;2934-2941.
175. Ing D., Zang J., Dzau V., Webster K., Bishopric N. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide. Bak, and Bcl-x. Circ Res. 84:1999;21-33.
176. Milting H., Bartling B., Schumann H., et al. Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy. Thorac Cardiovacs Surg. 47:1999;48-50.